TIDMOXB

RNS Number : 6468D

Oxford Biomedica PLC

01 February 2018

Oxford BioMedica

Total Voting Rights

Oxford, UK - 1 February 2018: Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), announces that in accordance with the FCA's Disclosure and Transparency Rule 5.6.1, the Company's issued share capital as at the close of business on 31 January 2018 consisted of 3,107,973,707 ordinary shares of 1 pence each ("Ordinary Shares"). There are no Ordinary Shares held in treasury.

Accordingly, the total number of voting rights in Oxford BioMedica plc at the date of this notice is 3,107,973,707.

The above figure (3,107,973,707) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Oxford BioMedica plc under the FCA's Disclosure and Transparency Rules.

- Ends -

 
 For further information, please 
  contact: 
  Oxford BioMedica plc:                       Tel: +44 (0)1865 
   John Dawson, Chief Executive Officer        783 000 
   Stuart Paynter, Chief Financial 
   Officer 
  Consilium Strategic Communications          Tel: +44 (0)20 
   Mary-Jane Elliott/Matthew Neal/Philippa     3709 5700 
   Gardner/Laura Thornton

Notes for editors

About Oxford BioMedica

Oxford BioMedica (LSE:OXB) is a leading gene and cell therapy group focused on developing life changing treatments for serious diseases. Oxford BioMedica and its subsidiaries (the "Group") have built a sector leading lentiviral vector delivery platform (LentiVector(R) ), which the Group leverages to develop in vivo and ex vivo products both in-house and with partners. The Group has created a valuable proprietary portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders. The Group has also entered into a number of partnerships, including with Novartis, Sanofi, GSK, Orchard Therapeutics and Immune Design, through which it has long-term economic interests in other potential gene and cell therapy products. Oxford BioMedica is based across several locations in Oxfordshire, UK and employs more than 300 people. Further information is available at www.oxfordbiomedica.co.uk.

This information is provided by RNS

The company news service from the London Stock Exchange

END

TVREAFAFEAKPEFF

(END) Dow Jones Newswires

February 01, 2018 06:28 ET (11:28 GMT)

Oxford Biomedica (LSE:OXB)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Oxford Biomedica Charts.
Oxford Biomedica (LSE:OXB)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Oxford Biomedica Charts.